UPDATE: Chardan Capital Markets Upgrades Adverum Biotechnologies (ADVM) to Buy
Tweet Send to a Friend
(Updated - February 10, 2020 9:55 AM EST)
Chardan Capital Markets analyst Gbola Amusa upgraded Adverum Biotechnologies (NASDAQ: ADVM) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Chardan Capital Markets analyst Gbola Amusa upgraded Adverum Biotechnologies (NASDAQ: ADVM) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
